BioSpecifics Merger Investigation: Halper Sadeh LLP Encourages BioSpecifics Technologies Corp. Shareholders to Contact the Firm – BSTC

Endo commenced a tender offer scheduled to expire on December 2, 2020 to acquire BioSpecifics common stock for $88.50 per share.